Company intelligence
Kedrion Biopharma US
The Power of Rare Connections
About Kedrion Biopharma US
At Kedrion, we believe that innovation and care must go hand in hand. Our mission is to enhance lives through our dedicated work in the field of rare and ultra-rare diseases. As a global leader with a passionate team of 5,200 employees, we collect and fractionate plasma to produce and distribute 38 vital medicines worldwide, establishing ourselves as the fifth largest player in the plasma-derived products sector. What truly sets us apart is our unwavering commitment to every detail, every person, and every interaction. Whether we are engaging with donors, supporting patients, or empowering our employees, we recognize that each connection we make has a meaningful impact. We refer to these as "rare connections," highlighting our belief that every relationship matters. In partnership with the medical and scientific community, institutions, patient advocacy groups, and research organizations, we drive sustainable innovation that improves patients' lives. Together, we are creating a brighter future for individuals and communities affected by rare diseases. Join us on this journey as we continue to enhance lives and foster connections that matter. Discover how you can contribute to our mission at Kedrion. This page is intended for US audiences only
Verified activity
Signals from Kedrion Biopharma US
3 published signals
Presence & Recognition
Kedrion Biopharma US hosted its annual Anti-D Celebration in Buffalo, New York, bringing together donors, patients, partners, and team members.
Reported by Kedrion Biopharma US
People
Kedrion Biopharma US recognized the legacy of longtime Anti-D donor Kathleen Starkey through the Kathleen Starkey Memorial Scholarship.
Reported by Kedrion Biopharma US
Presence & Recognition
Kedrion Biopharma US employee Gorana Dasic MD, MSc, VP and Head of Global Medical Affairs was featured on BloodStream Media's
Reported by Kedrion Biopharma US